CpG methylation inhibits proenkephalin gene expression and binding of the transcription factor AP-2 (original) (raw)
Journal Article
Department of Genetics, Harvard Medical School and Department of Molecular Biology, Massachusetts General Hospital
Boston, MA, 02114, USA
* To whom correspondence should be addressed at Laboratory of Molecular Neurobiology, Neuroscience Center, Massachusetts General Hospital (East), Charlestown, MA 02129, USA.
Search for other works by this author on:
Department of Genetics, Harvard Medical School and Department of Molecular Biology, Massachusetts General Hospital
Boston, MA, 02114, USA
Search for other works by this author on:
Received:
25 January 1990
PDF Cite
Michael Comb, Howard M. Goodman, CpG methylation inhibits proenkephalin gene expression and binding of the transcription factor AP-2, Nucleic Acids Research, Volume 18, Issue 13, 11 July 1990, Pages 3975–3982, https://doi.org/10.1093/nar/18.13.3975
Close
Navbar Search Filter Mobile Enter search term Search
Abstract
DNA methylation at Hpall (CmCGG) sites inhibits expression of a human proenkephalin-CAT fusion gene when it is transiently expressed in CV-1 cells or stably expressed in C6-glioma cells. The inhibitory effects of Hpall methylation have been mapped to a site within the human proenkephalin promoter located at position −72 relative to the start site of transcription. This region spans a cAMP and phorbol ester inducible enhancer and methylation at this position inhibits both basal transcription and transcription induced by either cAMP or TPA. The Hpall site is located within an element which binds the transcription factor AP-2. In vitro methylation at this Hpall site inhibits the binding of AP-2. These results suggest that CpG methylation inhibits proenkephalin gene expression by directly interfering with the binding of a positively acting transcription factor previously shown to be essential for maximal basal, cAMP, and TPA inducible transcription.
This content is only available as a PDF.
© Oxford University Press
I agree to the terms and conditions. You must accept the terms and conditions.
Submit a comment
Name
Affiliations
Comment title
Comment
You have entered an invalid code
Thank you for submitting a comment on this article. Your comment will be reviewed and published at the journal's discretion. Please check for further notifications by email.